SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the crypto market experiences volatility, with community members debating potential support levels and whether a deeper correction is coming. Mixed sentiment abounds, as some traders anticipate a bounce while others brace for further downside, referencing historical September weakness. Broader macroeconomic concerns, including a potential government shutdown, are also being discussed as possible contributing factors.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is experiencing volatility, prompting discussions around potential government shutdowns and the impact of overnight liquidations. Community members are debating whether this is a buying opportunity or a sign of deeper issues, with some pointing to market manipulation and others awaiting key price levels. Tom Lee's previous predictions are being questioned amidst the current price action.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to a recently announced $3 billion AI hosting deal with Fluidstack, backed by Google, which includes a significant equity stake. Despite the positive news, the stock's reaction is mixed as investors digest the details of an associated convertible note offering, sparking community debate about potential dilution. Some investors view this as a strategic move to expand AI capabilities, while others express concern about the near-term impact.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as the stock price dips following news of a $2.5 billion FTC settlement, with some traders believing this presents a buying opportunity while others anticipate further declines. Community discussions revolve around the impact of the settlement and the potential of Amazon's autonomous vehicle initiatives like Zoox. Analysts are weighing in with upgrades, but some investors express frustration with the stock's recent performance compared to its peers.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy (MSTR) is trending downwards, with community members pointing to its correlation with Bitcoin's recent struggles and potential dilution. Bears are celebrating the price action, while bulls are hoping for a turnaround and discussing key support levels. Chatter suggests traders are weighing whether to treat MSTR as a leveraged Bitcoin play or if the volatility risk is too high.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is trending as investors discuss its recent dip alongside Bitcoin's movements, with some expressing concerns about NAV erosion despite the attractive dividend yield. Community members are debating whether to reinvest dividends or seek alternative investments, while closely monitoring MSTR's performance and potential support levels. Discussions also revolve around the impact of Bitcoin's price on MSTY and MSTR, with some investors awaiting potential rate cuts and S&P 500 inclusion news.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending amidst discussions about its valuation, potential impact from tariffs, and recent executive membership policy changes. The community is weighing whether its defensive strength justifies its high P/E ratio, especially compared to competitors, while monitoring upcoming earnings for insights on consumer spending and tariff navigation. Some traders anticipate a potential stock split or special dividend, while others point to insider selling as a bearish indicator.

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

SciSparc Ltd

Scisparc Ltd

SPRC is trending due to community discussion around a quantum computing initiative for AI drug discovery, with retail traders debating its potential and the possibility of a short squeeze. Bullish investors are optimistic about the company's technology and are targeting a short burn, while bears point to potential dilution and low profitability. The stock's volatile price action and high short interest are also fueling the conversation.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

Lithium Americas Corp ($LAC) is trending due to speculation around a potential equity stake from the U.S. government as part of loan renegotiations, sparking excitement about energy independence and green/AI initiatives. The community is buzzing about the potential for a short squeeze and comparing it to previous government-backed success stories like $MP, while also debating the company's financial health and production timeline amid fluctuating lithium prices.

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

PepGen Inc

PEPG is trending as traders discuss the potential impact of recent trial results for its DM1 therapy and a newly announced public offering. Community members are weighing the positive data against concerns of dilution, speculating on potential short squeezes and future price movements. Bullish investors express confidence in the company's technology, while bears cite dilution as a reason for caution.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections

Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections Iterum Therapeutics to Host Morning...

Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC Research Report), Apollomics (AP...

Q4 2023 Iterum Therapeutics PLC Earnings Call Transcript

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
The post ITRM...

Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript

Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript...

Iterum Therapeutics sees cash runway into 2025

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Iterum Therapeutics reports Q4 EPS (81c) vs. (52c) last year

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

--Resubmission of NDA On Track for Early Q2 24 --Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN...

Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

DUBLIN, Ireland and CHICAGO, March 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation...

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

Iterum Therapeutics Plc

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Current Price	$0.73
Prev Close	$0.78
Open	$0.78
Dividend Yield	0.00%
50-Day Moving Average	$0.7459
Beta	0.89
Avg. Volume	1.05M
PE Ratio	-0.91

52-Week High	$3.02
52-Week Low	$0.6108
Market Capitalization	$34.83M
EPS (Annual)	-$1.26
Price to Book	-8.45
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ITRM
Iterum Therapeutics Plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ITRM News

ITRM Iterum Therapeutics Plc